Dr. Raychaudhuri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Education & Training
- Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 2018 - 2021
- Medical College of WisconsinClass of 2018
Certifications & Licensure
- WA State Medical License 2022 - 2026
- PA State Medical License 2018 - 2021
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma.Rafee Talukder, Dimitra Rafailia Bakaloudi, Dimitrios Makrakis, Leonidas N Diamantopoulos, Thomas Enright
Clinical Genitourinary Cancer. 2025-02-01 - Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Reco...Ruben Raychaudhuri, Makayla DeJong, Matthew Rettig, Evan Y Yu, Roman Gulati
European Urology. 2024-06-17 - 4 citationsGenomic Correlates of Prostate-Specific Membrane Antigen Expression and Response toLu-PSMA-617: A Retrospective Multicenter Cohort Study.Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, Laura Graham, Roman Gulati
JCO Precision Oncology. 2024-04-01
Press Mentions
- Fred Hutch at ASCO: New Insights on Financial Toxicity, Combination Therapies for Cancer and the Need for Targeted Breast Cancer Therapies in UgandaMay 26th, 2023
- Fred Hutch Experts Highlight Research on Cancer Treatment Advances, Survivorship and Precision Oncology at ASCOJune 6th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: